Global Aging And Healthcare Infrastructure Expansion Will Spur High-Value Injectables
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 12 Analysts
Published
04 Jul 25
Updated
15 Aug 25
AnalystHighTarget's Fair Value
₹2,340.00
15.7% undervalued intrinsic discount15 Aug
₹1,973.00
1Y
0.6%7D
1.9%